Roche Holding AG (RHHBY)
Health Care
RHHBY trades over the counter in the US on OTC Link. It represents shares of Roche Holding AG, which reports its financial results in CHF. SentiSense covers it in the Health Care sector.
Latest reported results
Roche Holding AG reported revenue of 31.02 billion CHF for Q2 FY2026, up 94.8% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 69 institutions reported holding RHHBY, with 5.5 million shares worth $281.2 million in aggregate. The largest reported holders were Aristotle Capital Management, Saratoga Research & Investment Management and Boston Common Asset Management. Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter.
More on RHHBY
- RHHBY sentiment: whether news and social coverage of Roche Holding AG leans bullish or bearish, and the stories driving it.
- RHHBY ownership: all 69 reporting institutions, plus insider and congressional trades.
- RHHBY financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
Frequently asked questions
What sector is RHHBY in?
SentiSense classifies Roche Holding AG in the Health Care sector.
Where does RHHBY stock trade?
RHHBY trades over the counter in the US on OTC Link. It represents shares of Roche Holding AG, which reports its financial results in CHF.
Who is the CEO of Roche Holding AG?
Thomas Schinecker is the chief executive officer of Roche Holding AG.
How many institutions own RHHBY?
69 institutions reported a position in RHHBY in 13F filings for the quarter ended June 30, 2026, worth $281.2 million in total.